|
NUDT9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81369999996406E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.17480000000081E-05 |
| Normal-vs-Stage2 |
4.668200E-02 |
| Normal-vs-Stage3 |
1.754070E-04 |
| Normal-vs-Stage4 |
5.354300E-02 |
| Stage1-vs-Stage2 |
5.657000E-01 |
| Stage1-vs-Stage3 |
1.620810E-01 |
| Stage1-vs-Stage4 |
8.211600E-01 |
| Stage2-vs-Stage3 |
1.136420E-01 |
| Stage2-vs-Stage4 |
5.254000E-01 |
| Stage3-vs-Stage4 |
5.266200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6379999999705E-06 |
| Normal-vs-AfricanAmerican |
2.822400E-03 |
| Normal-vs-Asian |
8.093800E-01 |
| Caucasian-vs-AfricanAmerican |
3.848000E-01 |
| Caucasian-vs-Asian |
5.858200E-01 |
| AfricanAmerican-vs-Asian |
6.992800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86061999999376E-05 |
| Normal-vs-Female |
3.12160000004447E-06 |
| Male-vs-Female |
3.831000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.835100E-03 |
| Normal-vs-Extreme_Weight |
7.94900000000709E-05 |
| Normal-vs-Obese |
3.67110000000226E-05 |
| Normal-vs-Extreme_Obese |
9.499800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.856000E-01 |
| Normal_Weight-vs-Obese |
7.362200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.093400E-01 |
| Extreme_Weight-vs-Obese |
9.396600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.716400E-02 |
| Obese-vs-Extreme_Obese |
2.266200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.122300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.410600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.34539999999228E-06 |
| Normal-vs-Age(81-100Yrs) |
2.519500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.683800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.931600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.755000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.679000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.100200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.945800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.45459999999431E-05 |
| Normal-VS-Type2 PRCC |
5.79929999999784E-05 |
| Normal-VS-KIRP CIMP |
9.54239999999551E-05 |
| Normal-VS-Unclassified PRCC |
6.161200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.412800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.337980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.482600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.201600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.872400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.840010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.542500E-03 |
| Normal-vs-N1 |
1.621120E-03 |
| Normal-vs-N2 |
6.21539999999809E-05 |
| N0-vs-N1 |
4.772000E-01 |
| N0-vs-N2 |
1.578450E-01 |
| N1-vs-N2 |
2.377600E-01 |
|
|
